TrialHepatology (Baltimore, Md.)2018

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.

Rohit Loomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.